رابطه بین سطح پلاسمایی لیپوپروتئین (a) و ریسک فاکتورهای ماژور قلبی عروقی در بیماران مبتلا به دیابت نوع2

Autor: بهرامی مطلق, هومن, نخجوانی, منوچهر, اصفهانیان, فاطمه, یعقوبی, محمد علی
Zdroj: Medical journal of Mashhad University of Medical Sciences; Jan/Feb2018, Vol. 60 Issue 6, p727-733, 7p
Abstrakt: Introduction: Lipoprotein a is a risk factor for coronary artery disease. Although many studies have been conducted in the non-diabetic population that shows the role of increasing plasma Lp (a) concentration and atherosclerotic disease, this role is not clear in the diabetic population. Therefore, the aim of this study was to determine the relationship between plasma lipoprotein levels and cardiovascular risk factors in patients with type 2 diabetes. Subjects & Methods: This study was performed in the diabetic clinic of Imam Khomeini Hospital in Tehran ,from 2005 to 2007. A total of 346 patients were selected from 600 patients with type 2 diabetes. To measure the association of high levels of Lp (a) and cardiovascular risk factors, patients were divided into two groups of normal Lp (a) (< 35mg / dl) levels and elevated levels of Lp (a) (> 35mg / dl) and risk factors between the two groups were compared by statistical tests. Results: Our results showed that there was a positive and significant correlation between Lp (a) and total cholesterol (r=0.217, P<0.001), HDL (r=0.141, P=0.008), LDL-C (r=0.241, P<0.001), apolipoprotein B (r=0.220, P<0.001) and Framingham Scoring System (FSS) (r=0.135, P=0.135) in patients. Mean cholesterol, LDL, HDL, apolipoprotein B and FSS levels were significantly higher in patients with Lp (a) ≥35mg /dl than those with normal Lp (a) level (<35mg /dl) (P<0.05). Conclusion: Serum levels of Lp (a) have a significant positive correlation with lipid variables (other than triglyceride) and higher levels than 35mg /dl with increased risk factors for cardiovascular disease in diabetic patients [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index